Clinical and Genetic Features of Patients With Type 2 Diabetes and Renal Glycosuria
Author(s) -
Siqian Gong,
Jiandong Guo,
Xueyao Han,
Meng Li,
Lingli Zhou,
Xiaoling Cai,
Yu Zhu,
Yingying Luo,
Simin Zhang,
Xianghai Zhou,
Yumin Ma,
Lig Ji
Publication year - 2017
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2016-2332
Subject(s) - glycosuria , medicine , diabetes mellitus , endocrinology , type 2 diabetes , urinary system , insulin resistance , type 2 diabetes mellitus
A sodium glucose cotransporter 2 (SGLT2) inhibitor, which increases urinary glucose excretion, was reported to decrease blood glucose levels and deaths among patients with type 2 diabetes mellitus (T2DM) and established cardiovascular disease. SLC5A2 and HNF1A mutations are associated with renal glycosuria, but their contributions to renal glycosuria in patients with T2DM are not well understood.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom